OC
CNCR

Oppenheimer & Co’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History

Oppenheimer & Co’s Portfolio CNCR Stock Details CNCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-10,213
Closed -$215K – 1318
2019
Q1 		$215K Sell
10,213
-14
-0.1% -$295 0.01% 1190
2018
Q4 		$193K Buy
10,227
+2,120
+26% +$40K 0.01% 1112
2018
Q3 		$201K Buy
+8,107
New +$201K 0.01% 1228